CervoMed Inc. Increase (Decrease) in Accounts Payable
CervoMed Inc. (CRVO) reported Increase (Decrease) in Accounts Payable of -$767.01 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2026-08-07
- CervoMed Inc. increase (decrease) in accounts payable for the quarter ending 2026-06-30 was -$1.53M.
- CervoMed Inc. increase (decrease) in accounts payable for the quarter ending 2026-03-31 was $765.36K, a 119.20% increase year-over-year.
- CervoMed Inc. increase (decrease) in accounts payable for the quarter ending 2025-12-31 was $94.90K, a 77.88% decline year-over-year.
- CervoMed Inc. increase (decrease) in accounts payable for the quarter ending 2025-09-30 was -$434.81K, a 221.94% decline year-over-year.
- CervoMed Inc. increase (decrease) in accounts payable for fiscal 2025 was -$67.32K, a 107.93% decline from fiscal 2024.
- CervoMed Inc. increase (decrease) in accounts payable for fiscal 2024 was $848.97K, a 50.22% increase from fiscal 2023.
- CervoMed Inc. increase (decrease) in accounts payable for fiscal 2023 was $565.17K, a 614.01% increase from fiscal 2022.
- CervoMed Inc. increase (decrease) in accounts payable for fiscal 2022 was $79.15K.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$767.01K 10-Q · filed 2026-08-07 | -$672.11K derived: sum of 3 quarters · filed 2026-08-07 | -$1.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $765.36K 10-Q · filed 2026-05-15 | $860.26K derived: sum of 2 quarters · filed 2026-05-15 | $425.45K derived: sum of 3 quarters · filed 2026-05-15 | $348.88K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $94.90K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$339.91K derived: sum of 2 quarters · filed 2026-03-13 | -$416.48K derived: sum of 3 quarters · filed 2026-08-07 | -$67.32K 10-K · filed 2026-03-13 |
| 2025-09-30 | -$434.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$511.38K derived: sum of 2 quarters · filed 2026-08-07 | -$162.22K 10-Q · filed 2025-11-07 | $266.78K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$76.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $272.59K 10-Q · filed 2026-08-07 | $701.60K derived: sum of 3 quarters · filed 2026-08-07 | $1.06M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $349.16K 10-Q · filed 2026-05-15 | $778.16K derived: sum of 2 quarters · filed 2026-05-15 | $1.13M derived: sum of 3 quarters · filed 2026-05-15 | $1.43M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $429.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $785.59K derived: sum of 2 quarters · filed 2026-03-13 | $1.08M derived: sum of 3 quarters · filed 2026-03-13 | $848.97K 10-K · filed 2026-03-13 |
| 2024-09-30 | $356.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $650.37K derived: sum of 2 quarters · filed 2025-11-07 | $419.96K 10-Q · filed 2025-11-07 | $602.46K derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | $293.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $63.38K 10-Q · filed 2025-08-08 | $245.88K derived: sum of 3 quarters · filed 2025-08-08 | $145.00K derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$230.40K 10-Q · filed 2025-05-12 | -$47.91K derived: sum of 2 quarters · filed 2025-05-12 | -$148.79K derived: sum of 3 quarters · filed 2025-05-12 | $94.51K derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $182.49K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | $81.61K derived: sum of 2 quarters · filed 2025-03-17 | $324.91K derived: sum of 3 quarters · filed 2025-03-17 | $565.17K 10-K · filed 2025-03-17 |
| 2023-09-30 | -$100.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $142.42K derived: sum of 2 quarters · filed 2024-11-12 | $382.68K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $243.30K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $483.56K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $240.26K 10-Q · filed 2024-05-14 | |||
| 2022-12-31 | $79.15K 10-K · filed 2024-03-29 | |||
| 2014-03-31 | $81.52K 10-Q · filed 2014-05-20 | $61.02K derived: sum of 2 quarters · filed 2014-05-20 | $246.94K derived: sum of 3 quarters · filed 2014-05-20 | $416.01K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-12-31 | -$20.50K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $165.42K derived: sum of 2 quarters · filed 2014-04-23 | $334.50K derived: sum of 3 quarters · filed 2014-04-23 | $316.82K 10-K/A · filed 2014-04-23 |
| 2013-09-30 | $185.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | $355.00K derived: sum of 2 quarters · filed 2013-11-19 | $337.32K 10-Q · filed 2013-11-19 | $568.98K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-06-30 | $169.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $151.40K 10-Q · filed 2013-08-14 | $383.06K derived: sum of 3 quarters · filed 2014-05-20 | $301.84K derived: sum of 4 quarters · filed 2014-05-20 |
| 2013-03-31 | -$17.67K 10-Q · filed 2014-05-20 | $213.98K derived: sum of 2 quarters · filed 2014-05-20 | $132.76K derived: sum of 3 quarters · filed 2014-05-20 | $206.11K derived: sum of 4 quarters · filed 2014-05-20 |
| 2012-12-31 | $231.65K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $150.44K derived: sum of 2 quarters · filed 2014-04-23 | $223.78K derived: sum of 3 quarters · filed 2014-04-23 | $414.36K 10-K/A · filed 2014-04-23 |
| 2012-09-30 | -$81.22K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-19 | -$7.87K derived: sum of 2 quarters · filed 2013-11-19 | $182.71K 10-Q · filed 2013-11-19 | $377.56K derived: sum of 4 quarters · filed 2013-11-19 |
| 2012-06-30 | $73.35K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-08-14 | $263.92K 10-Q · filed 2013-08-14 | $458.78K derived: sum of 3 quarters · filed 2013-08-14 | $423.99K derived: sum of 4 quarters · filed 2013-08-14 |
| 2012-03-31 | $190.58K 10-Q/A · filed 2013-05-20 | $385.43K derived: sum of 2 quarters · filed 2013-05-20 | $350.64K derived: sum of 3 quarters · filed 2013-05-20 | |
| 2011-12-31 | $194.86K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $160.06K derived: sum of 2 quarters · filed 2013-04-24 | -$114.24K 10-K/A · filed 2013-04-24 | |
| 2011-09-30 | -$34.79K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | -$309.09K 10-Q · filed 2012-11-19 | ||
| 2011-06-30 | -$274.30K 10-Q/A · filed 2012-09-07 | |||
| 2010-12-31 | $269.76K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-21 | $345.93K derived: sum of 2 quarters · filed 2012-05-21 | $518.31K 10-K · filed 2012-05-21 | |
| 2010-09-30 | $76.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $248.55K 10-Q · filed 2011-11-21 | ||
| 2010-06-30 | $172.38K 10-Q · filed 2011-08-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |